logo
  • Home
  • News
Menu

Stock market update: Nifty Pharma index advances 0.41% in an upbeat market

Home / Stock Analysis / Stock market update: Nifty Pharma index advances 0.41% in an upbeat market
Article feature image

Stock market update: Nifty Pharma index advances 0.41% in an upbeat market

14 Sep Stock Analysis

NEW DELHI: The Nifty Pharma index traded positive around 10:19AM (IST) on Tuesday in an upbeat market. Divis Laboratories (up 1.12 per cent), Dr Reddys Laboratories (up 0.64 per cent), Sun Pharmaceutical Industries (up 0.35 per cent), Alkem Laboratories…

Click here to view the original article.

Tags:
Global, The Times of India
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

rtx-stock-after-hours-dec-12-2025-citis-new-buy-call-fresh-pentagon-export-notices-and-what-to-watch.jpeg
+

Citi’s New “Buy” Call, Fresh Pentagon Export Notices, and What to Watch Before the Next Market Open

13 Dec Stock Analysis
tata-steel-share-price-stock-closes-near-e282b9172-as-india-expansion-roadmap-takes-center-stage-ana.jpeg
+

Stock Closes Near ₹172 as India Expansion Roadmap Takes Center Stage; Analysts’ Targets Span ₹175–₹210 (Dec 13, 2025)

13 Dec Stock Analysis

recent post

  • rtx-stock-after-hours-dec-12-2025-citis-new-buy-call-fresh-pentagon-export-notices-and-what-to-watch.jpeg

    Citi’s New “Buy” Call, Fresh Pentagon

    Dec 13 2025
  • 693d37b4f38159f3d804084b_693d37b379279441f707c26d_lastImage.png

    Coinbase and Kalshi’s Partnership: A Look

    Dec 13 2025
  • tata-steel-share-price-stock-closes-near-e282b9172-as-india-expansion-roadmap-takes-center-stage-ana.jpeg

    Stock Closes Near ₹172 as India

    Dec 13 2025
  • 7488239b8ef9e6dd91eccb8234da29a1.jpeg

    3 Predictions for Crypto in 2026

    Dec 13 2025
  • tesla-stock-tsla-in-december-2025-robotaxis-ev-slowdown-and-price-targets-to-2030-featured.jpg

    Robotaxis, EV Slowdown and Price Targets

    Dec 13 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.